
ZGN Valuation
Ermenegildo Zegna NV
ZGN Relative Valuation
ZGN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ZGN is overvalued; if below, it's undervalued.
Historical Valuation
Ermenegildo Zegna NV (ZGN) is now in the Fair zone, suggesting that its current forward PE ratio of 21.72 is considered Fairly compared with the five-year average of 19.53. The fair price of Ermenegildo Zegna NV (ZGN) is between 5.18 to 11.82 according to relative valuation methord.
Relative Value
Fair Zone
5.18-11.82
Current Price:9.81
Fair
21.72
PE
1Y
3Y
5Y
Trailing
Forward
7.19
EV/EBITDA
Ermenegildo Zegna NV. (ZGN) has a current EV/EBITDA of 7.19. The 5-year average EV/EBITDA is 7.47. The thresholds are as follows: Strongly Undervalued below 5.65, Undervalued between 5.65 and 6.56, Fairly Valued between 8.38 and 6.56, Overvalued between 8.38 and 9.29, and Strongly Overvalued above 9.29. The current Forward EV/EBITDA of 7.19 falls within the Historic Trend Line -Fairly Valued range.
16.86
EV/EBIT
Ermenegildo Zegna NV. (ZGN) has a current EV/EBIT of 16.86. The 5-year average EV/EBIT is 15.10. The thresholds are as follows: Strongly Undervalued below 11.78, Undervalued between 11.78 and 13.44, Fairly Valued between 16.76 and 13.44, Overvalued between 16.76 and 18.42, and Strongly Overvalued above 18.42. The current Forward EV/EBIT of 16.86 falls within the Overvalued range.
8.55
PS
Ermenegildo Zegna NV. (ZGN) has a current PS of 8.55. The 5-year average PS is 1.41. The thresholds are as follows: Strongly Undervalued below 0.03, Undervalued between 0.03 and 0.72, Fairly Valued between 2.10 and 0.72, Overvalued between 2.10 and 2.79, and Strongly Overvalued above 2.79. The current Forward PS of 8.55 falls within the Strongly Overvalued range.
5.82
P/OCF
Ermenegildo Zegna NV. (ZGN) has a current P/OCF of 5.82. The 5-year average P/OCF is 5.35. The thresholds are as follows: Strongly Undervalued below -1.80, Undervalued between -1.80 and 1.77, Fairly Valued between 8.93 and 1.77, Overvalued between 8.93 and 12.50, and Strongly Overvalued above 12.50. The current Forward P/OCF of 5.82 falls within the Historic Trend Line -Fairly Valued range.
14.64
P/FCF
Ermenegildo Zegna NV. (ZGN) has a current P/FCF of 14.64. The 5-year average P/FCF is 27.43. The thresholds are as follows: Strongly Undervalued below -24.75, Undervalued between -24.75 and 1.34, Fairly Valued between 53.52 and 1.34, Overvalued between 53.52 and 79.61, and Strongly Overvalued above 79.61. The current Forward P/FCF of 14.64 falls within the Historic Trend Line -Fairly Valued range.
Ermenegildo Zegna NV (ZGN) has a current Price-to-Book (P/B) ratio of 2.45. Compared to its 3-year average P/B ratio of 3.10 , the current P/B ratio is approximately -20.80% higher. Relative to its 5-year average P/B ratio of 2.79, the current P/B ratio is about -12.07% higher. Ermenegildo Zegna NV (ZGN) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 7.52%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 7.40% , the current FCF yield is about -100.00% lower.
2.45
P/B
Median3y
3.10
Median5y
2.79
7.65
FCF Yield
Median3y
7.52
Median5y
7.40
Competitors Valuation Multiple
The average P/S ratio for ZGN's competitors is 50.50, providing a benchmark for relative valuation. Ermenegildo Zegna NV Corp (ZGN) exhibits a P/S ratio of 8.55, which is -83.06% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of ZGN increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of ZGN in the past 1 year is driven by Unknown.
People Also Watch

EVTC
Evertec Inc
27.300
USD
-2.81%

BKV
BKV Corp
25.390
USD
+2.54%

XTLB
X T L Biopharmaceuticals Ltd
1.000
USD
0.00%

CRTO
Criteo SA
21.420
USD
-4.80%

CNMD
Conmed Corp
43.970
USD
-0.54%

INTR
Inter & Co Inc
9.460
USD
0.00%

SUPN
Supernus Pharmaceuticals Inc
46.020
USD
-2.63%

GBX
Greenbrier Companies Inc
43.070
USD
+0.98%

CLOV
Clover Health Investments Corp
2.670
USD
+2.30%

MTRN
Materion Corp
116.110
USD
+0.84%
FAQ
Is Ermenegildo Zegna NV (ZGN) currently overvalued or undervalued?
Ermenegildo Zegna NV (ZGN) is now in the Fair zone, suggesting that its current forward PE ratio of 21.72 is considered Fairly compared with the five-year average of 19.53. The fair price of Ermenegildo Zegna NV (ZGN) is between 5.18 to 11.82 according to relative valuation methord.








